TETRAPHASE PHARMACEUTICALS INC 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Jan 29, 2014
Insider Transaction Report
Form 4
Sutcliffe Joyce A.
Senior Vice President, Biology
Transactions
- Exercise/Conversion
Common Stock
2014-01-17$0.87/sh+51,724$45,000→ 51,724 total - Exercise/Conversion
Employee Stock Option (right to buy)
2014-01-17+51,724→ 0 totalExercise: $0.87Exp: 2023-09-11→ Common Stock (51,724 underlying)
Footnotes (1)
- [F1]The options vested as to 25% of the shares on September 11, 2010 and as to an additional 1/16 of the shares quarterly thereafter.